Silvio R. Meier

507 total citations
13 papers, 383 citations indexed

About

Silvio R. Meier is a scholar working on Physiology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Silvio R. Meier has authored 13 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 7 papers in Molecular Biology and 6 papers in Computational Theory and Mathematics. Recurrent topics in Silvio R. Meier's work include Alzheimer's disease research and treatments (11 papers), Computational Drug Discovery Methods (6 papers) and Prion Diseases and Protein Misfolding (3 papers). Silvio R. Meier is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Computational Drug Discovery Methods (6 papers) and Prion Diseases and Protein Misfolding (3 papers). Silvio R. Meier collaborates with scholars based in Sweden, United Kingdom and Switzerland. Silvio R. Meier's co-authors include Dag Sehlin, Stina Syvänen, Greta Hultqvist, Xiaotian T. Fang, Lars Lannfelt, Sahar Roshanbin, Gunnar Antoni, Ulf Neumann, Joakim Bergström and Johanna Rokka and has published in prestigious journals such as Biomaterials, NeuroImage and Scientific Reports.

In The Last Decade

Silvio R. Meier

13 papers receiving 378 citations

Peers

Countries citing papers authored by Silvio R. Meier

Since Specialization

Citations

This map shows the geographic impact of Silvio R. Meier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvio R. Meier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvio R. Meier more than expected).

Fields of papers citing papers by Silvio R. Meier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvio R. Meier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvio R. Meier. The network helps show where Silvio R. Meier may publish in the future.

Co-authorship network of co-authors of Silvio R. Meier

This figure shows the co-authorship network connecting the top 25 collaborators of Silvio R. Meier. A scholar is included among the top collaborators of Silvio R. Meier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvio R. Meier. Silvio R. Meier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion 2024 ·Acta Neuropathologica Communications ·(unknown), Stina Syvänen, Vilmantas Giedraitis, Monique Hooley, (unknown), Silvio R. Meier, Johanna Rokka, Jonas Eriksson, (unknown), Tara L. Spires‐Jones, Lars Lannfelt, Lars Nilsson, Anna Erlandsson, Greta Hultqvist, Martin Ingelsson, Dag Sehlin	5
2	In vivo imaging of alpha-synuclein with antibody-based PET 2022 ·Neuropharmacology ·Sahar Roshanbin, (unknown), Greta Hultqvist, Linda Söderberg, Olof Zachrisson, Silvio R. Meier, Sara Ekmark‐Lewén, Joakim Bergström, Martin Ingelsson, Dag Sehlin, Stina Syvänen	40
3	A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice 2022 ·Neurotherapeutics ·(unknown), Silvio R. Meier, Nicole G. Metzendorf, Jamie I. Morrison, (unknown), Stina Syvänen, Dag Sehlin, Greta Hultqvist	26
4	Passive and receptor mediated brain delivery of an anti-GFAP nanobody 2022 ·Nuclear Medicine and Biology ·Silvio R. Meier, Dag Sehlin, Stina Syvänen	10
5	PET Imaging in Preclinical Anti-Aβ Drug Development 2022 ·Pharmaceutical Research ·Stina Syvänen, Silvio R. Meier, Sahar Roshanbin, (unknown), (unknown), Tobias Gustavsson, (unknown), (unknown), (unknown), Ulrika Julku, Jonas Eriksson, Dag Sehlin	11
6	Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer’s Disease 2021 ·Molecular Imaging and Biology ·Silvio R. Meier, Dag Sehlin, Greta Hultqvist, Stina Syvänen	23
7	¹¹C-PiB and¹²⁴I-Antibody PET Provide Differing Estimates of Brain Amyloid-β After Therapeutic Intervention 2021 ·Journal of Nuclear Medicine ·Silvio R. Meier, Dag Sehlin, Sahar Roshanbin, (unknown), Takashi Saito, Takaomi C. Saido, Ulf Neumann, Johanna Rokka, Jonas Eriksson, Stina Syvänen	32
8	Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer’s disease 2019 ·Journal of Neurochemistry ·Wojciech Michno, (unknown), Silvio R. Meier, Dag Sehlin, Stina Syvänen, Henrik Zetterberg, Kaj Blennow, Jörg Hanrieder	19
9	Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition 2018 ·Journal of Nuclear Medicine ·Silvio R. Meier, Stina Syvänen, Greta Hultqvist, Xiaotian T. Fang, Sahar Roshanbin, Lars Lannfelt, Ulf Neumann, Dag Sehlin	43
10	High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain 2018 ·NeuroImage ·Xiaotian T. Fang, Greta Hultqvist, Silvio R. Meier, Gunnar Antoni, Dag Sehlin, Stina Syvänen	60
11	A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils – a new concept for neuroimaging 2017 ·NeuroImage ·Stina Syvänen, Xiaotian T. Fang, Greta Hultqvist, Silvio R. Meier, Lars Lannfelt, Dag Sehlin	47
12	Pharmacokinetics, biodistribution and brain retention of a bispecific antibody-based PET radioligand for imaging of amyloid-β 2017 ·Scientific Reports ·Dag Sehlin, Xiaotian T. Fang, Silvio R. Meier, (unknown), Stina Syvänen	48
13	Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis 2015 ·Biomaterials ·Silvio R. Meier, Gerhard Pütz, Ulrich Massing, Christoph E. Hagemeyer, Dominik von Elverfeldt, Matthias Meißner, (unknown), Sabine Barnert, Karlheinz Peter, (unknown), Rolf Schubert, Constantin von zur Mühlen	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact